DuPont: New Trial, Remittitur Warranted In C8 Case That Resulted In $5.6M Award

(September 21, 2016, 10:47 AM EDT) -- COLUMBUS, Ohio — E.I. du Pont de Nemours and Co. on Sept. 19 filed a brief in Ohio federal court seeking judgment as a matter of law or a new trial and remittitur on the cancer claims of David Freeman, who won a combined $5.6 million in compensatory and punitive damages against the company for cancer stemming from exposure to perfluorooctanoic acid (known as C8) (In re E.I. du Pont de Nemours and Co. C8 Personal Injury Litigation, MDL No. 2433, No. 13-2433, S.D. Ohio)....
To view the full article, register now.